Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Recombinant GH on Intima-Media Thickness at Common Carotids and on Cardiovascular Risk Factors in Hypopituitary Patients

NCT00462475 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT00462475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00462475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Recombinant GH on Intima-Media Thickness at Common Carotids and on Cardiovascular Risk Factors in Hypopituitary Patients
Lead sponsor
Federico II University
Phase
Observational
Overall status
Completed
Start date
January 31, 1996
Completion date
December 31, 2006
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency, hypopituitarism, pituitary tumors